Drug insight: Mechanisms and sites of action of ursodeoxycholic acid in cholestasis.
about
Intrahepatic cholestasis of pregnancyQ24186229Bile acid derivatives for people with primary sclerosing cholangitisNovel bile acid therapeutics for the treatment of chronic liver diseasesA review of the medical treatment of primary sclerosing cholangitis in the 21st centuryThe role of ursodeoxycholic acid in non-alcoholic steatohepatitis: a systematic reviewPrimary biliary cirrhosis and liver transplantationPrimary biliary cirrhosis: Pathophysiology, clinical presentation and therapyUrsodeoxycholic Acid and S-adenosylmethionine for the Treatment of Intrahepatic Cholestasis of Pregnancy: A Meta-analysisTauroursodeoxycholic acid prevents hearing loss and hair cell death in Cdh23(erl/erl) mice.Up-regulation of microRNA 506 leads to decreased Cl-/HCO3- anion exchanger 2 expression in biliary epithelium of patients with primary biliary cirrhosis.A mutation in the canalicular phospholipid transporter gene, ABCB4, is associated with cholestasis, ductopenia, and cirrhosis in adults.Protein Kinases C-Mediated Regulations of Drug Transporter Activity, Localization and Expression.Biliary physiology and disease: reflections of a physician-scientist.Ursodeoxycholic acid is conjugated with taurine to promote secretin-stimulated biliary hydrocholeresis in the normal rat.Biliary secretion of S-nitrosoglutathione is involved in the hypercholeresis induced by ursodeoxycholic acid in the normal rat.Endoplasmic reticulum chaperon tauroursodeoxycholic acid alleviates obesity-induced myocardial contractile dysfunctionPregnancy and ABCB4 gene mutation: risk of recurrent cholelithiasis.Swertianlarin, isolated from Swertia mussotii Franch, increases detoxification enzymes and efflux transporters expression in rats.Microbiome and cancer.Primary biliary cirrhosis associated with systemic sclerosis: diagnostic and clinical challenges.Unusual binding of ursodeoxycholic acid to ileal bile acid binding protein: role in activation of FXRαEndoplasmic reticulum stress-mediated apoptotic pathway is involved in corpus luteum regression in ratsFunctional and structural features of cholangiocytes in health and disease.Ursodeoxycholic acid inhibits hepatic cystogenesis in experimental models of polycystic liver disease.Advances in pharmacotherapy for primary biliary cirrhosis.Combination of ursodeoxycholic acid and glucocorticoids upregulates the AE2 alternate promoter in human liver cellsMechanisms of disease: mechanisms and clinical implications of cholestasis in sepsis.Untargeted Metabolomics Reveals Dose-Response Characteristics for Effect of Rhubarb in a Rat Model of CholestasisThe unfinished business of primary biliary cirrhosisPrenatal sensitization of a postnatal trigger for metabolic disease.An open-label randomized control study to compare the efficacy of vitamin e versus ursodeoxycholic acid in nondiabetic and noncirrhotic Indian NAFLD patients.Serum bile acid profiling reflects enterohepatic detoxification state and intestinal barrier function in inflammatory bowel disease.Intrahepatic cholestasis of pregnancy-current achievements and unsolved problemsImmune-mediated liver diseases: programmed cell death ligands and circulating apoptotic markers.Efficacy of ursodeoxycholic acid for Japanese patients with autoimmune hepatitis.Cutting-edge issues in primary biliary cirrhosis.Genetic variations of bile salt transporters as predisposing factors for drug-induced cholestasis, intrahepatic cholestasis of pregnancy and therapeutic response of viral hepatitis.Role of the anion exchanger 2 in the pathogenesis and treatment of primary biliary cirrhosis.Molecular targets for the treatment of fibrosing cholangiopathies.
P2860
Q21202971-6019FD18-F0C6-4ED9-942C-EAB0101AA6DBQ24186229-A3EA2EBD-142F-48BF-AD7C-C2D01FB86E0DQ24186230-E6FF14A4-E583-4D7E-A3C6-101B00CD562CQ26748613-CBA9CF4F-3504-4D32-8035-071EA689CABEQ26771816-1136DE50-1EDF-4C2E-8550-E5B58CC137F3Q26825269-7A5E72F4-384B-46C6-AE01-6CA839BA9076Q26853145-2F93C2F1-C1FA-49D4-AAFB-3F14B1CB7445Q26853649-4111215B-E6D7-4716-8EDA-A6835D00F011Q28078484-F3DF9693-8CAD-41C5-A6CB-AB9984545DECQ30362420-78C6EF66-8E52-4793-8FBD-CBB90AA0E8C8Q30522942-92C02531-D149-4A9C-85D0-35235F2D1273Q33368134-D64F627E-1264-48B2-A4E2-C4AF49723BEEQ33624522-FB009181-7E03-4B5F-8D40-B98C7F10275FQ34108895-BD8556FD-887C-4289-8442-8945FA391FE2Q34110298-1B40E28E-B0D6-439A-BE07-3FCB025ACC6EQ34129606-F3CA6A26-6EAC-473C-A4E8-14A287F4996AQ34478713-EAFE20AC-9EB9-4893-B248-8300AC449605Q35015855-DAB245BD-D607-496E-80E8-81B4FF5A88D7Q35145151-8C2F4AE8-B53A-466E-A19E-D00802D597FDQ35430806-23485F4A-55F3-4DD3-9F77-16C0F3D1A3F1Q35609106-BD1D6B93-6D71-4A3E-97BC-2CCE12E116FFQ35839661-7DC67324-7752-4B8B-B8C4-A3AF815B16D1Q35902115-6D68225D-E662-4A7B-B657-189C8C93F9C3Q35933236-3714C70F-542F-4BD9-BA7E-07C2BA252FF9Q36075389-07347319-882C-4D14-8135-8D6337DB6781Q36116022-BE9C32B3-4561-42AB-8DEF-E8A47D8FFC35Q36330872-B0010AA4-C19A-402B-B5FF-980A3AB30CE4Q36606886-0C9FDCC6-05B4-4940-AAD3-76A2C1604386Q36748184-995ED087-A125-4796-9FAA-060CE6EA2885Q36914332-954C68A1-C5FF-40A6-9B11-B3951680BEC6Q36967001-B97D0579-3578-4AE7-A6E8-74B96F40FB8DQ36981317-72DF1981-B1C4-4812-9C4D-48605F89F7A2Q37250362-6E38FF95-A6D9-4F4C-9E2D-F2F67F6A9916Q37294587-51CE3768-56FA-4264-ABEA-9D163E93CAC4Q37418054-FFD42F9D-69C8-4167-98A9-3745BDAF1C2CQ37466226-7B7631BD-9489-43C9-8BFA-56611428F74DQ37829668-9183E4C4-66A0-47D5-A04F-631CD0271B1CQ37841614-89C613DA-A975-405C-BD56-7C3FB1BCA0D2Q37892296-27F7D7CF-0D50-45E6-8F33-6B61831D2EC9Q38031095-A2644A41-E495-44CD-AD11-47B5E2FE9865
P2860
Drug insight: Mechanisms and sites of action of ursodeoxycholic acid in cholestasis.
description
2006 nî lūn-bûn
@nan
2006年の論文
@ja
2006年学术文章
@wuu
2006年学术文章
@zh-cn
2006年学术文章
@zh-hans
2006年学术文章
@zh-my
2006年学术文章
@zh-sg
2006年學術文章
@yue
2006年學術文章
@zh
2006年學術文章
@zh-hant
name
Drug insight: Mechanisms and sites of action of ursodeoxycholic acid in cholestasis.
@ast
Drug insight: Mechanisms and sites of action of ursodeoxycholic acid in cholestasis.
@en
type
label
Drug insight: Mechanisms and sites of action of ursodeoxycholic acid in cholestasis.
@ast
Drug insight: Mechanisms and sites of action of ursodeoxycholic acid in cholestasis.
@en
prefLabel
Drug insight: Mechanisms and sites of action of ursodeoxycholic acid in cholestasis.
@ast
Drug insight: Mechanisms and sites of action of ursodeoxycholic acid in cholestasis.
@en
P2860
P356
P1476
Drug insight: Mechanisms and sites of action of ursodeoxycholic acid in cholestasis.
@en
P2093
Ulrich Beuers
P2860
P2888
P304
P356
10.1038/NCPGASTHEP0521
P407
P577
2006-06-01T00:00:00Z